350 related articles for article (PubMed ID: 14707282)
1. MDM2, an introduction.
Iwakuma T; Lozano G
Mol Cancer Res; 2003 Dec; 1(14):993-1000. PubMed ID: 14707282
[TBL] [Abstract][Full Text] [Related]
2. p53-independent functions of MDM2.
Ganguli G; Wasylyk B
Mol Cancer Res; 2003 Dec; 1(14):1027-35. PubMed ID: 14707286
[TBL] [Abstract][Full Text] [Related]
3. Nucleolar Arf sequesters Mdm2 and activates p53.
Weber JD; Taylor LJ; Roussel MF; Sherr CJ; Bar-Sagi D
Nat Cell Biol; 1999 May; 1(1):20-6. PubMed ID: 10559859
[TBL] [Abstract][Full Text] [Related]
4. MDM2-ARF complex regulates p53 sumoylation.
Chen L; Chen J
Oncogene; 2003 Aug; 22(34):5348-57. PubMed ID: 12917636
[TBL] [Abstract][Full Text] [Related]
5. Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4.
Chandler DS; Singh RK; Caldwell LC; Bitler JL; Lozano G
Cancer Res; 2006 Oct; 66(19):9502-8. PubMed ID: 17018606
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle regulatory functions of the human oncoprotein MDM2.
Deb SP
Mol Cancer Res; 2003 Dec; 1(14):1009-16. PubMed ID: 14707284
[TBL] [Abstract][Full Text] [Related]
7. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
Honda R; Yasuda H
EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
[TBL] [Abstract][Full Text] [Related]
8. Mdmx as an essential regulator of p53 activity.
Marine JC; Jochemsen AG
Biochem Biophys Res Commun; 2005 Jun; 331(3):750-60. PubMed ID: 15865931
[TBL] [Abstract][Full Text] [Related]
9. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
Wang C; Ivanov A; Chen L; Fredericks WJ; Seto E; Rauscher FJ; Chen J
EMBO J; 2005 Sep; 24(18):3279-90. PubMed ID: 16107876
[TBL] [Abstract][Full Text] [Related]
10. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
Swaroop M; Sun Y
Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
[TBL] [Abstract][Full Text] [Related]
11. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
[TBL] [Abstract][Full Text] [Related]
12. Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization.
Lohrum MA; Ashcroft M; Kubbutat MH; Vousden KH
Curr Biol; 2000 May; 10(9):539-42. PubMed ID: 10801444
[TBL] [Abstract][Full Text] [Related]
13. MDM2--master regulator of the p53 tumor suppressor protein.
Momand J; Wu HH; Dasgupta G
Gene; 2000 Jan; 242(1-2):15-29. PubMed ID: 10721693
[TBL] [Abstract][Full Text] [Related]
14. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.
Weber JD; Kuo ML; Bothner B; DiGiammarino EL; Kriwacki RW; Roussel MF; Sherr CJ
Mol Cell Biol; 2000 Apr; 20(7):2517-28. PubMed ID: 10713175
[TBL] [Abstract][Full Text] [Related]
15. Effects of MdmX on Mdm2-mediated downregulation of pRB.
Uchida C; Miwa S; Isobe T; Kitagawa K; Hattori T; Oda T; Yasuda H; Kitagawa M
FEBS Lett; 2006 Mar; 580(7):1753-8. PubMed ID: 16510145
[TBL] [Abstract][Full Text] [Related]
16. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function.
Lu W; Pochampally R; Chen L; Traidej M; Wang Y; Chen J
Oncogene; 2000 Jan; 19(2):232-40. PubMed ID: 10645001
[TBL] [Abstract][Full Text] [Related]
17. An essential function of the extreme C-terminus of MDM2 can be provided by MDMX.
Uldrijan S; Pannekoek WJ; Vousden KH
EMBO J; 2007 Jan; 26(1):102-12. PubMed ID: 17159902
[TBL] [Abstract][Full Text] [Related]
18. The contribution of the RING finger domain of MDM2 to cell cycle progression.
Argentini M; Barboule N; Wasylyk B
Oncogene; 2000 Aug; 19(34):3849-57. PubMed ID: 10951578
[TBL] [Abstract][Full Text] [Related]
19. Mdm2: A regulator of cell growth and death.
Vargas DA; Takahashi S; Ronai Z
Adv Cancer Res; 2003; 89():1-34. PubMed ID: 14587869
[TBL] [Abstract][Full Text] [Related]
20. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
